Treatment of essential tremor with long-chain alcohols: still experimental or ready for prime time?
Ontology highlight
ABSTRACT: To review current literature on long-chain alcohols and their derivatives as novel pharmacotherapy for the treatment of essential tremor (ET). Currently available and recommended pharmacotherapies for ET are often limited by suboptimal treatment effects, frequent adverse effects, and drug interactions. While ethanol is reported to profoundly decrease tremor severity in the majority of patients with ET, preclinical experience suggests that long-chain alcohols such as 1-octanol might lead to a comparable tremor reduction without ethanol's typical side effects of sedation and intoxication. Here, we review the literature on the first clinical trials on 1-octanol and its metabolite octanoic acid (OA) for the treatment of ET. The literature on preclinical and clinical trials on long-chain alcoho
SUBMITTER: Haubenberger D
PROVIDER: S-EPMC3918508 | biostudies-literature | 2014
REPOSITORIES: biostudies-literature
ACCESS DATA